These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1926 related articles for article (PubMed ID: 22591948)

  • 1. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
    Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male sexual dysfunction after rectal cancer surgery: Results of a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for patients with lower rectal cancer: Japan Clinical Oncology Group Study JCOG0212.
    Saito S; Fujita S; Mizusawa J; Kanemitsu Y; Saito N; Kinugasa Y; Akazai Y; Ota M; Ohue M; Komori K; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2016 Dec; 42(12):1851-1858. PubMed ID: 27519616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
    Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
    Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
    Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Tsukamoto S; Fujita S; Ota M; Mizusawa J; Shida D; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Tsuchida A; Okamura S; Akagi Y; Takiguchi N; Saida Y; Akasu T; Moriya Y;
    Br J Surg; 2020 Apr; 107(5):586-594. PubMed ID: 32162301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral pelvic lymph node dissection using latero-vesical approach with aspiration procedure for advanced lower rectal cancer.
    Kawahara H; Watanabe K; Ushigome T; Yanagisawa S; Kobayashi S; Yanaga K
    Hepatogastroenterology; 2012; 59(113):116-9. PubMed ID: 21940358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes.
    Liang JT; Huang KC; Lai HS; Lee PH; Sun CT
    Ann Surg Oncol; 2007 Jul; 14(7):1980-90. PubMed ID: 17458586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
    Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication and benefit of pelvic sidewall dissection for rectal cancer.
    Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
    Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
    Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
    Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
    Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
    Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
    Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer.
    Akasu T; Sugihara K; Moriya Y
    Ann Surg Oncol; 2009 Oct; 16(10):2779-86. PubMed ID: 19626377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
    Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic coloanal anastomosis with or without intersphincteric resection for low rectal cancer: starting with the perianal approach followed by robotic procedure.
    Kang J; Hur H; Min BS; Lee KY; Kim NK
    Ann Surg Oncol; 2012 Jan; 19(1):154-5. PubMed ID: 21822556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Lymph Node Yield Is Associated With Improved Survival in Rectal Cancer Irrespective of Neoadjuvant Treatment: Results From a National Cohort Study.
    Lykke J; Jess P; Roikjaer O;
    Dis Colon Rectum; 2015 Sep; 58(9):823-30. PubMed ID: 26252843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.